UBS Group Begins Coverage on Clover Health Investments (NASDAQ:CLOV)

UBS Group assumed coverage on shares of Clover Health Investments (NASDAQ:CLOV – Free Report) in a research note published on Monday, MarketBeat Ratings reports. The firm issued a neutral rating and a $4.00 price target on the stock. Clover Health Investments Stock Performance Shares of NASDAQ:CLOV opened at $3.91 on Monday. Clover Health Investments has […]

Leave a Reply

Your email address will not be published.

Previous post Contrasting Bright Green (NASDAQ:BGXX) & Curaleaf (OTCMKTS:CURLF)
Next post Jefferies Financial Group Lowers Evotec (NASDAQ:EVO) to Hold